PERHA PHARMACEUTICALS

ManRos Therapeutics is a biotechnology start-up whose creation relies on pharmacological inhibitors of protein kinases developed by the CNRS unit previously headed by Laurent MEIJER. The objectives of ManRos are the identification, characterization, optimization and preclinical and clinical development of pharmacological inhibitors of kinases (some are derived from marine natural products) for their use for the treatment of cystic fibrosis, polycystic kidney disease, Down syndrome and Alzheimer’s disease.